222 related articles for article (PubMed ID: 24912481)
1. A 1536-well fluorescence polarization assay to screen for modulators of the MUSASHI family of RNA-binding proteins.
Minuesa G; Antczak C; Shum D; Radu C; Bhinder B; Li Y; Djaballah H; Kharas MG
Comb Chem High Throughput Screen; 2014; 17(7):596-609. PubMed ID: 24912481
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction.
Wu X; Lan L; Wilson DM; Marquez RT; Tsao WC; Gao P; Roy A; Turner BA; McDonald P; Tunge JA; Rogers SA; Dixon DA; Aubé J; Xu L
ACS Chem Biol; 2015 Jun; 10(6):1476-84. PubMed ID: 25750985
[TBL] [Abstract][Full Text] [Related]
3. Crystal and solution structures of human oncoprotein Musashi-2 N-terminal RNA recognition motif 1.
Lan L; Xing M; Kashipathy M; Douglas J; Gao P; Battaile K; Hanzlik R; Lovell S; Xu L
Proteins; 2020 Apr; 88(4):573-583. PubMed ID: 31603583
[TBL] [Abstract][Full Text] [Related]
4. Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins.
Lan L; Liu H; Smith AR; Appelman C; Yu J; Larsen S; Marquez RT; Wu X; Liu FY; Gao P; Gowthaman R; Karanicolas J; De Guzman RN; Rogers S; Aubé J; Neufeld KL; Xu L
BMC Cancer; 2018 Aug; 18(1):809. PubMed ID: 30097032
[TBL] [Abstract][Full Text] [Related]
5. Applying a high-throughput fluorescence polarization assay for the discovery of chemical probes blocking La:RNA interactions in vitro and in cells.
Sommer G; Fedarovich A; Kota V; Rodriguez R; Smith CD; Heise T
PLoS One; 2017; 12(3):e0173246. PubMed ID: 28291789
[TBL] [Abstract][Full Text] [Related]
6. Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.
Kudinov AE; Karanicolas J; Golemis EA; Boumber Y
Clin Cancer Res; 2017 May; 23(9):2143-2153. PubMed ID: 28143872
[TBL] [Abstract][Full Text] [Related]
7. The Msi Family of RNA-Binding Proteins Function Redundantly as Intestinal Oncoproteins.
Li N; Yousefi M; Nakauka-Ddamba A; Li F; Vandivier L; Parada K; Woo DH; Wang S; Naqvi AS; Rao S; Tobias J; Cedeno RJ; Minuesa G; Y K; Barlowe TS; Valvezan A; Shankar S; Deering RP; Klein PS; Jensen ST; Kharas MG; Gregory BD; Yu Z; Lengner CJ
Cell Rep; 2015 Dec; 13(11):2440-2455. PubMed ID: 26673327
[TBL] [Abstract][Full Text] [Related]
8. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.
Yi C; Li G; Ivanov DN; Wang Z; Velasco MX; Hernández G; Kaundal S; Villarreal J; Gupta YK; Qiao M; Hubert CG; Hart MJ; Penalva LOF
RNA Biol; 2018; 15(11):1420-1432. PubMed ID: 30362859
[TBL] [Abstract][Full Text] [Related]
9. High-throughput fluorescence anisotropy screen for inhibitors of the oncogenic mRNA binding protein, IMP-1.
Mahapatra L; Mao C; Andruska N; Zhang C; Shapiro DJ
J Biomol Screen; 2014 Mar; 19(3):427-36. PubMed ID: 24108120
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of an
Lan L; Liu J; Xing M; Smith AR; Wang J; Wu X; Appelman C; Li K; Roy A; Gowthaman R; Karanicolas J; Somoza AD; Wang CCC; Miao Y; De Guzman R; Oakley BR; Neufeld KL; Xu L
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784494
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast Cancer.
Haiduk TS; Sicking M; Brücksken KA; Espinoza-Sánchez NA; Eder KM; Kemper B; Eich HT; Götte M; Greve B; Troschel FM
Arch Med Res; 2023 Sep; 54(6):102855. PubMed ID: 37481823
[TBL] [Abstract][Full Text] [Related]
12. High-throughput screen for the chemical inhibitors of antiapoptotic bcl-2 family proteins by multiplex flow cytometry.
Curpan RF; Simons PC; Zhai D; Young SM; Carter MB; Bologa CG; Oprea TI; Satterthwait AC; Reed JC; Edwards BS; Sklar LA
Assay Drug Dev Technol; 2011 Oct; 9(5):465-74. PubMed ID: 21561376
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function.
Grover P; Shi H; Baumgartner M; Camacho CJ; Smithgall TE
PLoS One; 2015; 10(7):e0133590. PubMed ID: 26222440
[TBL] [Abstract][Full Text] [Related]
14. Time-Resolved Fluorescence Resonance Energy Transfer Assay for Discovery of Small-Molecule Inhibitors of Methyl-CpG Binding Domain Protein 2.
Wyhs N; Walker D; Giovinazzo H; Yegnasubramanian S; Nelson WG
J Biomol Screen; 2014 Aug; 19(7):1060-9. PubMed ID: 24608100
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a high-density fluorescence polarization-based assay for the trypanosoma RNA triphosphatase TbCet1.
Antczak C; Shum D; Radu C; Seshan VE; Djaballah H
Comb Chem High Throughput Screen; 2009 Mar; 12(3):258-68. PubMed ID: 19275531
[TBL] [Abstract][Full Text] [Related]
16. High-throughput fluorescence polarization assay for chemical library screening against anti-apoptotic Bcl-2 family member Bfl-1.
Zhai D; Godoi P; Sergienko E; Dahl R; Chan X; Brown B; Rascon J; Hurder A; Su Y; Chung TD; Jin C; Diaz P; Reed JC
J Biomol Screen; 2012 Mar; 17(3):350-60. PubMed ID: 22156224
[TBL] [Abstract][Full Text] [Related]
17. Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase II.
Alquicer G; Sedlák D; Byun Y; Pavlícek J; Stathis M; Rojas C; Slusher B; Pomper MG; Bartunek P; Barinka C
J Biomol Screen; 2012 Sep; 17(8):1030-40. PubMed ID: 22751730
[TBL] [Abstract][Full Text] [Related]
18. Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1.
Lan L; Appelman C; Smith AR; Yu J; Larsen S; Marquez RT; Liu H; Wu X; Gao P; Roy A; Anbanandam A; Gowthaman R; Karanicolas J; De Guzman RN; Rogers S; Aubé J; Ji M; Cohen RS; Neufeld KL; Xu L
Mol Oncol; 2015 Aug; 9(7):1406-20. PubMed ID: 25933687
[TBL] [Abstract][Full Text] [Related]
19. A dual-readout F2 assay that combines fluorescence resonance energy transfer and fluorescence polarization for monitoring bimolecular interactions.
Du Y; Nikolovska-Coleska Z; Qui M; Li L; Lewis I; Dingledine R; Stuckey JA; Krajewski K; Roller PP; Wang S; Fu H
Assay Drug Dev Technol; 2011 Aug; 9(4):382-93. PubMed ID: 21395401
[TBL] [Abstract][Full Text] [Related]
20. Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer's disease.
Sengupta U; Montalbano M; McAllen S; Minuesa G; Kharas M; Kayed R
Acta Neuropathol Commun; 2018 Oct; 6(1):113. PubMed ID: 30367664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
